Morning Briefing
Summaries of health policy coverage from major news organizations
Overhaul May Cost Drugmakers More Than Expected
The health law will likely cost drugmakers $25 billion more than the $80 billion the industry anticipated when it agreed to back the Democratic-led effort, according to Wall Street analysts.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
